Chemistry: molecular biology and microbiology – Spore forming or isolating process
Patent
1989-02-17
1992-11-10
Weimar, Elizabeth C.
Chemistry: molecular biology and microbiology
Spore forming or isolating process
935103, 935106, 436513, 5303881, 5303882, 5303884, 42524027, C12N 1500, C12N 500, H01R 3108, A61K 3900
Patent
active
051622238
ABSTRACT:
A panel of monoclonal antibody (Mab) producing hybridomas directed against various antigens of Bordetella pertussis are disclosed herein. The hybridomas and the antigens that the resulting monoclonals are directed against include: (1) BPG10F8C3 and BPE8D8B1--lipooligosaccharide A (LOS A), serotype 1; (2) BPD5, BPE6, and BPF2--fimbriae, serotype 2; (3) BPE3, BPE8 and BPD8--69 kDa nonfimbrial protein, serotype 3; and (4) BPB7, BPC10, BPD4, BPD6, BPD9, and BPF5--fimbriae, serotype 6.
REFERENCES:
Abstracts and Program of the Sixth International Symposium on Pertussis, Mandark, Charles R. 1990, (ed) Dept. of Health & Human Services, Pub. No. (FDA) 90-1162, pp. 145-146, Leininger et al.
Pollack et al., "Specificity and Cross-Reactivity of Monoclonal Antibodies Reactive with the Core and Lipid A Regions of Bacterial Lipopolysaccharide," Journal of Infectious Diseases, vol. 159, No. 2, Feb. 1989, pp. 168-188.
Brennan et al., Inf & Immun. 56(12):3189. 1988.
Li et al., Inf & Immun. 56(3):699. 1988.
Li et al., Inf & Immun. 56(12):3184. 1988.
Gustafson et al., J. Clin. Microbiol. 26(19):2077. 1988.
Girard et al., Immunology 56:481. 1985.
Brennan Michael J.
Li Zhong Ming
Manclark Charles R.
The United States of America as represented by the Secretary of
Weimar Elizabeth C.
Ziska Suzanne
LandOfFree
Hybridomas and resulting monoclonal antibodies directed against does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Hybridomas and resulting monoclonal antibodies directed against , we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hybridomas and resulting monoclonal antibodies directed against will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2291900